Literature DB >> 12454024

Missing expression of pRb2/p130 in human retinoblastomas is associated with reduced apoptosis and lesser differentiation.

Cristiana Bellan1, Giulia De Falco, Gian Marco Tosi, Stefano Lazzi, Filomena Ferrari, Giovanna Morbini, Sabrina Bartolomei, Paolo Toti, Paola Mangiavacchi, Gabriele Cevenini, Carmela Trimarchi, Caterina Cinti, Antonio Giordano, Lorenzo Leoncini, Piero Tosi, Hans Cottier.   

Abstract

PURPOSE: Although the retinoblastoma gene (RB/p105) has been intensely investigated as a prototype suppressor gene in humans, mutational data on the Rb family member pRb2/p130 (p130) has only recently been reported. A protective role against apoptosis has been suggested for pRb/p105, both in vitro and in vivo. However, only limited information is available on the role of pRb2/p130 in controlling apoptosis. The purpose of this study was to determine the extent of a role of this gene in the neoplasms that give the Rb family its name.
METHODS: Forty-two human retinoblastomas were retrospectively examined by immunohistochemical labeling of the Rb-related proteins and the results compared with cellular kinetic characteristics: the apoptotic index (AI) and the mitotic index (MI).
RESULTS: The retinoblastomas that did not express p130 showed a significantly lower AI than those that expressed p130. This result was also supported by flow cytometry on a human Saos-2 cell line that was transiently transfected with RB2/p130. The p130(-) tumors displayed a lesser degree of differentiation than the p130(+) ones.
CONCLUSIONS: These observations give evidence that expression of p130 is inversely correlated with higher rates of apoptosis in human retinoblastomas and give an additional example of this regulator's role in cellular differentiation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12454024

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2.

Authors:  Taylor P Enrico; Wayne Stallaert; Elizaveta T Wick; Peter Ngoi; Xianxi Wang; Seth M Rubin; Nicholas G Brown; Jeremy E Purvis; Michael J Emanuele
Journal:  Elife       Date:  2021-12-01       Impact factor: 8.140

2.  miR-106a represses the Rb tumor suppressor p130 to regulate cellular proliferation and differentiation in high-grade serous ovarian carcinoma.

Authors:  Zhaojian Liu; Elizabeth Gersbach; Xiyu Zhang; Xiaofei Xu; Ruifen Dong; Peng Lee; Jinsong Liu; Beihua Kong; Changshun Shao; Jian-Jun Wei
Journal:  Mol Cancer Res       Date:  2013-09-17       Impact factor: 5.852

3.  Cell type-specific effects of Rb deletion in the murine retina.

Authors:  David MacPherson; Julien Sage; Teresa Kim; Dennis Ho; Margaret E McLaughlin; Tyler Jacks
Journal:  Genes Dev       Date:  2004-07-01       Impact factor: 11.361

4.  RBL2/p130 is a direct AKT target and is required to induce apoptosis upon AKT inhibition in lung cancer and mesothelioma cell lines.

Authors:  Francesca Pentimalli; Iris M Forte; Luca Esposito; Paola Indovina; Carmelina A Iannuzzi; Luigi Alfano; Caterina Costa; Daniela Barone; Gaetano Rocco; Antonio Giordano
Journal:  Oncogene       Date:  2018-04-02       Impact factor: 9.867

Review 5.  RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy.

Authors:  Paola Indovina; Francesca Pentimalli; Nadia Casini; Immacolata Vocca; Antonio Giordano
Journal:  Oncotarget       Date:  2015-07-20

6.  Time-course gene profiling and networks in demethylated retinoblastoma cell line.

Authors:  Federico Malusa; Monia Taranta; Nazar Zaki; Caterina Cinti; Enrico Capobianco
Journal:  Oncotarget       Date:  2015-09-15

Review 7.  Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer.

Authors:  David Frescas; Michele Pagano
Journal:  Nat Rev Cancer       Date:  2008-06       Impact factor: 60.716

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.